» Articles » PMID: 40004753

Changes in the Expression Profile of Growth-Associated Protein 43 in Degenerative Lumbosacral Stenosis

Overview
Journal J Clin Med
Specialty General Medicine
Date 2025 Feb 26
PMID 40004753
Authors
Affiliations
Soon will be listed here.
Abstract

Degenerative spinal stenosis is a common condition associated with structural degeneration and pain, yet its molecular underpinnings remain incompletely understood. Growth-associated protein 43 (GAP-43), a key player in neuronal plasticity and regeneration, may serve as a biomarker for disease progression and pain severity. This study investigates the expression of GAP-43 at the mRNA and protein levels in the ligamentum flavum of affected patients. Samples were collected from 96 patients with degenerative spinal stenosis and 85 controls. mRNA expression was analyzed using reverse transcription-quantitative polymerase chain reaction (RT-qPCR), while protein levels were quantified via enzyme-linked immunosorbent assay (ELISA) and Western blot. Pain severity was assessed using the visual analog scale (VAS), and associations with lifestyle factors were analyzed. mRNA expression was significantly downregulated in the study group compared to the controls (fold change = 0.58 ± 0.12, < 0.05), with an inverse correlation to VAS pain severity (fold change = 0.76 at VAS 4 vs. 0.36 at VAS 10). Conversely, GAP-43 protein levels were markedly elevated in the study group (5.57 ± 0.21 ng/mL) when compared to controls (0.54 ± 0.87 ng/mL, < 0.0001). Protein levels were also correlated with lifestyle factors, including smoking and alcohol consumption ( < 0.05). GAP-43 shows potential as a biomarker for pain severity and disease progression in degenerative spinal stenosis, in a manner influenced by lifestyle factors. Further research is needed to explore its diagnostic and therapeutic applications.

References
1.
Koshi T, Ohtori S, Inoue G, Ito T, Yamashita M, Yamauchi K . Lumbar posterolateral fusion inhibits sensory nerve ingrowth into punctured lumbar intervertebral discs and upregulation of CGRP immunoreactive DRG neuron innervating punctured discs in rats. Eur Spine J. 2009; 19(4):593-600. PMC: 2899833. DOI: 10.1007/s00586-009-1237-9. View

2.
Diz J, de Souza Moreira B, Felicio D, Teixeira L, de Jesus-Moraleida F, de Queiroz B . Brain-derived neurotrophic factor plasma levels are increased in older women after an acute episode of low back pain. Arch Gerontol Geriatr. 2017; 71:75-82. DOI: 10.1016/j.archger.2017.03.005. View

3.
Ayyalasomayajula N, Bandaru M, Dixit P, Ajumeera R, Chetty C, Challa S . Inactivation of GAP-43 due to the depletion of cellular calcium by the Pb and amyloid peptide induced toxicity: An in vitro approach. Chem Biol Interact. 2019; 316:108927. DOI: 10.1016/j.cbi.2019.108927. View

4.
Sobanski D, Staszkiewicz R, Sobanska M, Strojny D, Grabarek B . Effects of pain in lumbosacral stenosis and lifestyle-related factors on brain-derived neurotrophic factor expression profiles. Mol Pain. 2025; 21():17448069241309001. PMC: 11705318. DOI: 10.1177/17448069241309001. View

5.
Byvaltsev V, Kalinin A, Hernandez P, Shepelev V, Pestryakov Y, Aliyev M . Molecular and Genetic Mechanisms of Spinal Stenosis Formation: Systematic Review. Int J Mol Sci. 2022; 23(21). PMC: 9658491. DOI: 10.3390/ijms232113479. View